Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID‐19 patients

• Asıl Yazarlar: Bruce M. Hendry (Yazar), Nina Stafford (Yazar), Ahran D. Arnold (Yazar), Arvind Sangwaiya (Yazar), Vijay Manglam (Yazar), Stuart D. Rosen (Yazar), Jayantha Arnold (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wiley, 2020-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract We propose a new hypothesis that the established drug pentoxifylline deserves attention as a potential repurposed therapeutic for COVID‐19. Pentoxifylline is an immunomodulator with anti‐inflammatory properties. It is a nonselective phosphodiesterase inhibitor and through Adenosine A2A Rece...